The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIxico Share News (IXI)

Share Price Information for Ixico (IXI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.375
Bid: 7.25
Ask: 7.50
Change: -0.25 (-3.28%)
Spread: 0.25 (3.448%)
Open: 7.625
High: 7.625
Low: 7.375
Prev. Close: 7.625
IXI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS AND TRADING: Ixico revenue falls, Solid State boosts profit

Tue, 05th Dec 2023 14:31

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Ixico PLC - London-based precision analytics company working to advance investigational therapies for neurological diseases - Revenue for the year that ended on September 30 falls 23% to GBP6.7 million from GBP8.6 million the year before. Company swings to GBP1.4 million pretax loss following a GBP885,000 profit. Total operating expenses increase to GBP5.1 million from GBP5.0 million. Ixico says revenue drop was expected and caused by the now-realised impact of clients ceasing multiple large "failed" trials across 2021 and early 2022. Expects to deliver roughly flat revenue in the current financial year before returning to growth in 2025.

----------

Supply@Me Capital PLC - London-based fintech platform provider - Says it has so far received GBP1.4 million from The AvantGarde Group SpA as a result of contractual payments. An additional GBP1.5 million remains outstanding. Also says it has made significant progress in the formalisation of its first White-Label IM agreement with an Italian banking group with a transaction valued at up to EUR10 million. Company is also working to finalise a framework to issue security tokens up to USD100 million to be subscribed in tranches.

----------

Lindsell Train Investment Trust PLC - London-based, rail-focused investment trust - Net asset value at September 30 is GBP968.75 per share, down from GBP1,056.95 at March 31. NAV total return for the six months to September 30 is negative 3.6%, underperforming the MSCI World Index with positive 4.5%. Says performance was impacted by high interest rates and inflation, and believes it may have to reduce its dividend. Notes reduced investor risk appetites and increased market volatility.

----------

Marechale Capital PLC - London-based corporate finance adviser - Revenue for the half year that ended on October 31 increased 91% to GBP320,603 from GBP168,001. Cost of sales more than doubles to GBP226,790 from GBP95,981. Pretax loss narrows to GBP155,803 from GBP179,502. Marechale says market is still challenging, especially in the hospitality sector, but that it remains positive about the outlook for its investments.

----------

Anglesey Mining PLC - Base metals miner with operations in North Wales, Sweden and Canada - Says drilling of the NCZ001 hole in the Northern Copper Zone at its Parys Mountain project on the Isle of Anglesey commenced on October 27, and is expected to complete over the next week. Expects results in the first quarter of 2024. Says initial logging suggests sulphide mineralisation commencing at around 350 metres deep. Chief Executive Jo Battershill says initial core is "very encouraging" as "we are seeing a significant amount of quartz veins within the system..[which] contain encouraging amounts of chalcopyrite, sphalerite, and galena – the key minerals that host copper, zinc and lead."

----------

Psych Capital PLC - London-based psychedelic medicines media firm and investor - Oscillate PLC continues to own 46.0 million shares in Psych, representing 12.75% of its issued share capital, following Psych's acquisition of Short Wave Pharma Inc which completed in November. Oscillate says it will continue to assess the investment to ascertain an exit opportunity. Says it meanwhile remains "optimistic at the advances that the Short Wave acquisition represents in the innovative psychedelics space." Oscillate also says that trials are due to start in the first quarter of 2024.

----------

Solid State PLC - Redditch, England-based supplier & design-in manufacturer of computing, power, and communications products - Pretax profit for the six months to September 30 is GBP6.1 million, up 45% from GBP4.2 million the prior year. Revenue increases 48% to GBP88.1 million from GBP59.4 million. Company declares 7.0 pence per share interim dividend, up 8% from 6.5p the year before. Says it is confident in meeting expectations for full-year results thanks to "record billings" and a "stable six-month order book". Open order book at October 31 stood at GBP108.6 million, slightly down from GBP112.5 million at September 30, 2022.

----------

By Emma Curzon, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
20 Oct 2016 11:01

Ixico pens deal to help develop a therapy for Parkinson's like diesease

(ShareCast News) - Shares in AIM-listed Ixico rose above 22% on Thursday, as the brain health company announced it had signed a $1.2m contract with a global pharmaceutical for imaging clinical trial services for a Parkinson's-like neurodegenerative disease. The project is for a second phase clinical

Read more
10 Oct 2016 12:26

Ixico to receive €1m from EU Alzheimer's project

(ShareCast News) - AIM-listed pharmaceutical Ixico is to receive €1m as a partner in an EU public-private consortium, which has the potential for long-term revenue through the development of diagnostic and disease management technologies for Alzheimer's. Ixico is to work on the Amyloid Imaging to Pr

Read more
2 Jun 2016 16:27

IXICO study joins Dementias Platform

(ShareCast News) - Brain health company IXICO announced on Thursday that its Cygnus study has joined the high-profile Dementias Platform UK (DPUK). The AIM-traded firm described Cygnus as a real-world digital data collection study from people with cognitive impairment and dementia. It said the four

Read more
18 Jan 2016 13:51

Ixico wins four new contracts worth over £3m

(ShareCast News) - Brain health company Ixico was recently awarded four new contracts with "leading" pharmaceutical groups and a specialist biotechnology firm totalling over £3m in value. The contracts involve global clinical trials of novel drugs for Alzheimer's disease spanning three major phases

Read more
19 Oct 2015 12:33

Ixico full-year income in line with expectations

(ShareCast News) - Brain health company Ixico reported revenues for the year of £3.1m and other income at £1m, in line with market expectations and giving a total combined income of £4.1m. This was down from £4.3m for the 16-month period to 30 September 2014. In a pre-close trading update ahead of

Read more
29 Jun 2015 11:11

Ixico secures two clinical trial contracts alongside partner VirtualScopics

Ixico has won two contracts to deploy its products in unnamed pharmaceutical companies' clinical trials, alongside its partner VirtualScopics. Both studies will employ Ixico's TrialTracker digital platform to collect and image data, one pertaining to metastatic solid tumours and the other to rare ne

Read more
17 Sep 2014 08:48

IXICO Appoints CFO For October 1 Start

Read more
21 Jul 2014 15:45

DIRECTOR DEALINGS: IXICO Divisional Vice-President Buys Shares

Read more
18 Jul 2014 07:25

UK MORNING BRIEFING: Shares Lower On Ukraine Crash, Gaza Offensive

Read more
19 Jun 2014 10:40

IXICO Joins Medical Research Council Collaboration For Dementia Drive

LONDON (Alliance News) - IXICO PLC said Thursday it will take part in a GBP16 million collaboration launched by publicly funded government agency the Medical Research Council to speed up research into dementia. The MRC has launched the UK Dementias Research Platform with the aim of seeking

Read more
19 Jun 2014 08:30

Ixico partners with the Medical Research Council to launch UK Dementias Research Platform

Biotechnology group Ixico has partnered with the Medical Research Council (MRC) to launch the UK Dementias Research Platform (UKDP), a £16m public-private partnership. The group, which set up the partnership to speed up research into dementias, will act as the MRC's imaging partner on the project a

Read more
6 Jun 2014 09:20

IXICO To Meet Full-Year Expectations As Interim Hit By Listing Costs

LONDON (Alliance News) - IXICO PLC expressed confidence Friday in meeting market expectations for the full year, as it swung into a loss in the half year to end-March, hit by costs relating to its AIM listing and a decline in revenues. The company was formed via the reverse takeover of Phyt

Read more
22 May 2014 12:07

IXICO Wins Contracts For Huntington's Disease Clinical Trials

LONDON (Alliance News) - Brain health company IXICO PLC Thursday said it has won contracts for two separate clinical trials in Huntington's disease with "top 15" pharmaceutical companies, building on a third clinical study already underway on the disease. In a statement, IXICO said the two

Read more
16 Apr 2014 09:54

IXICO Awarded Development Contract By NHS England Initiative

LONDON (Alliance News) - IXICO PLC Wednesday said it has been awarded a development contract by The Small Business Research Initiative for Healthcare, an NHS England initiative, to cover phase 1 funding for the development of an online application designed to support dementia sufferers after they

Read more
16 Apr 2014 07:33

UK MORNING BRIEFING: RSA Loses UK & Western Europe Chief Executive

LONDON (Alliance News) - RSA Insurance Group said Wednesday the Chief Executive of the business which houses its troubled Irish operations has resigned in order to become Executive Chairman, underwriting and distribution, at business partner A J.Gallagher. The company said UK & Western Euro

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.